BackLiminatus Pharma Warrants Overview

Liminatus Pharma Warrants Net Tangible Assets

Track Liminatus Pharma Warrants's net tangible assets ($-17M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$-17.32M
106.97% YoYΔ $-265.85M vs prior year quarter

Peer average

Loading

Liminatus Pharma Warrants Net Tangible Assets History

Loading

Liminatus Pharma Warrants vs. peers: Net Tangible Assets Comparison

Loading

Liminatus Pharma Warrants Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Liminatus Pharma Warrants (LIMNW) FAQ

As of the most recent data (March 2022), LIMNW shows a net tangible assets of $-17M. That compares with $250M in the prior-year period — down 107.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LIMNW's net tangible assets is now $-17M (was $250M) — a 107.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Liminatus Pharma Warrants is outperforming or lagging.

Tracking LIMNW's net tangible assets over time shows whether Liminatus Pharma Warrants is scaling, shrinking, or reshaping that part of the business. The current reading is $-17M That compares with $250M in the prior-year period — down 107.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Liminatus Pharma Warrants's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $-17M) with ownership activity and broader fundamentals.